These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 25745368)

  • 41. Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis.
    Ravelli A; Moretti C; Temporini F; Rossi F; Magni-Manzoni S; Pistorio A; Martini A
    Clin Exp Rheumatol; 2002; 20(4):569-72. PubMed ID: 12175118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.
    de Rotte MCFJ; Pluijm SMF; de Jong PHP; Bulatović Ćalasan M; Wulffraat NM; Weel AEAM; Lindemans J; Hazes JMW; de Jonge R
    PLoS One; 2018; 13(12):e0208534. PubMed ID: 30532219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis.
    Hinks A; Moncrieffe H; Martin P; Ursu S; Lal S; Kassoumeri L; Weiler T; Glass DN; Thompson SD; Wedderburn LR; Thomson W
    Ann Rheum Dis; 2011 Aug; 70(8):1395-400. PubMed ID: 21515602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study.
    van der Meer A; Wulffraat NM; Prakken BJ; Gijsbers B; Rademaker CM; Sinnema G
    Clin Exp Rheumatol; 2007; 25(3):480-5. PubMed ID: 17631750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis.
    Yanagimachi M; Naruto T; Hara T; Kikuchi M; Hara R; Miyamae T; Imagawa T; Mori M; Kaneko T; Morita S; Goto H; Yokota S
    Br J Clin Pharmacol; 2011 Feb; 71(2):237-43. PubMed ID: 21219404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
    Schmeling H; Biber D; Heins S; Horneff G
    J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
    Alsufyani K; Ortiz-Alvarez O; Cabral DA; Tucker LB; Petty RE; Malleson PN
    J Rheumatol; 2004 Jan; 31(1):179-82. PubMed ID: 14705239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
    Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
    Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methotrexate Hepatotoxicity in Children with Juvenile Idiopathic Arthritis: A Single-Center Study.
    Yassin NA; Haroon M; Elhamshary A
    Curr Rheumatol Rev; 2021; 17(2):242-246. PubMed ID: 33308133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of methotrexate in juvenile idiopathic arthritis.
    Ramanan AV; Whitworth P; Baildam EM
    Arch Dis Child; 2003 Mar; 88(3):197-200. PubMed ID: 12598376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
    Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
    Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations between gene polymorphisms and treatment outcomes of methotrexate in patients with juvenile idiopathic arthritis.
    Chen Y; Zou K; Sun J; Yang Y; Liu G
    Pharmacogenomics; 2018 Apr; 19(6):529-538. PubMed ID: 29589488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Children with juvenile idiopathic arthritis frequently experience interruptions to their medical therapy.
    Kazamia K; Holmquist L; Fagerlund A; Berntson L
    Acta Paediatr; 2014 May; 103(5):529-36. PubMed ID: 24517256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay.
    Möhlmann JE; de Roock S; Egas AC; Weijden ET; Doeleman MJH; Huitema ADR; van Luin M; Swart JF
    Pediatr Rheumatol Online J; 2024 May; 22(1):52. PubMed ID: 38715014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lung function in children and adolescents with juvenile idiopathic arthritis during long-term treatment with methotrexate: a retrospective study.
    Leiskau C; Thon A; Gappa M; Dressler F
    Clin Exp Rheumatol; 2012; 30(2):302-7. PubMed ID: 22409955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
    Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A
    Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis.
    Ćalasan MB; van den Bosch OF; Creemers MC; Custers M; Heurkens AH; van Woerkom JM; Wulffraat NM
    Arthritis Res Ther; 2013; 15(6):R217. PubMed ID: 24345416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High doses of infliximab in the management of juvenile idiopathic arthritis.
    Tambralli A; Beukelman T; Weiser P; Atkinson TP; Cron RQ; Stoll ML
    J Rheumatol; 2013 Oct; 40(10):1749-55. PubMed ID: 23950184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
    Hissink Muller PC; Brinkman DM; Schonenberg D; Koopman-Keemink Y; Brederije IC; Bekkering WP; Kuijpers TW; van Rossum MA; van Suijlekom-Smit LW; van den Berg JM; Allaart CF; Ten Cate R
    Pediatr Rheumatol Online J; 2017 Feb; 15(1):11. PubMed ID: 28166785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Methotrexate in the therapy of juvenile idiopathic arthritis].
    Holzinger D; Frosch M; Föll D
    Z Rheumatol; 2010 Aug; 69(6):496-504. PubMed ID: 20632181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.